Non-Structural protein 1 (NS1) gene of Canine Parvovirus-2 regresses chemically induced skin tumors in Wistar rats

Research in Veterinary Science

Volumn 97, Issue 2, 2014, Pages 292-296

  Santra, Lakshman ^a   Rajmani, R S ^a   Ravi Kumar, G V P P S ^a   Saxena, Shikha ^a   Dhara, Sujoy K ^a   Kumar, Amit ^a   Sahoo, Aditya Prasad ^a   Singh, Lakshya Veer ^a   Desai, G S ^a   Chaturvedi, Uttara ^a   Kumar, Sudesh ^a   Tiwari, Ashok K ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Anti tumor immunity; Canine parvovirus 2 NS1 gene; DMBA; Squamous cell carcinoma; Tumor regression; Viral gene oncotherapy

Indexed keywords

NONSTRUCTURAL PROTEIN 1; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; NS1 PROTEIN, PARVOVIRUS; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; NONSTRUCTURAL PROTEIN 1 GENE; POLYMORPHONUCLEAR CELL; RAT; SKIN TUMOR; TUMOR REGRESSION; ANIMAL; CANINE PARVOVIRUS; CARCINOMA, SQUAMOUS CELL; CHEMICALLY INDUCED; DISEASE MODEL; DOG; DOG DISEASES; GENE THERAPY; GENETICS; MITOSIS INDEX; PATHOLOGY; PROCEDURES; SKIN NEOPLASMS; TREATMENT OUTCOME; VETERINARY; WISTAR RAT;

CANINE PARVOVIRUS 2; RATTUS NORVEGICUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; GENETIC THERAPY; MALE; MITOTIC INDEX; PARVOVIRUS, CANINE; RATS; RATS, WISTAR; SKIN NEOPLASMS; TREATMENT OUTCOME; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84925200980     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2014.07.024     Document Type: Article

References (33)

1. Alderton, G.K., Bordon, Y., 2012. Tumour immunotherapy - leukocytes take up the fight. Nature Reviews. Immunology 12, 235.
2. Baak, J.P., Gudlaugsson, E., Skaland, I., Guo, L.H., Klos, J., Lende, T.H., et al., 2009. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Research and Treatment 115, 241-254.
3. Brown, C.J., Lain, S., Verma, C.S., Fersht, A.R., Lane, D.P., 2009. Awakening guardian angels: drugging the p53 pathway. Nature Reviews. Cancer 9, 862-873.
4. Brown, J.M., Attardi, L.D., 2005. The role of apoptosis in cancer development and treatment response. Nature Reviews. Cancer 5, 231-237.
5. Crocker, J., Boldy, D.A., Egan, M.J., 1989. How should we count AgNORS? Proposals for a standardized approach. The Journal of Pathology 158, 185-188.
6. Derenzini, M., Pession, A., Trere, D., 1990. Quantity of nucleolar silver-stained proteins is related to proliferating activity in cancer cells. Laboratory Investigation; A Journal of Technical Methods and Pathology 63, 137-140.
7. Essers, J., Theil, A.F., Baldeyron, C., van Cappellen, W.A., Houtsmuller, A.B., Kanaar, R., et al., 2005. Nuclear dynamics of PCNA in DNA replication and repair. Molecular and Cellular Biology 25, 9350-9359.
8. Farkas, J.P., Richardson, J.A., Hoopman, J.E., Brown, S.A., Kenkel, J.M., 2008. TUNEL assay for histopathologic evaluation of irreversible chromosomal damage following nonablative fractional photothermolysis. Plastic and Reconstructive Surgery 122, 1660-1668.
9. Fischer, U., Schulze-Osthoff, K., 2005. Apoptosis-based therapies and drug targets. Cell Death and Differentiation 12 (Suppl. 1), 942-961.
10. Hall, P.A., Levison, D.A.,Woods, A.L., Yu, C.C., Kellock, D.B.,Watkins, J.A., et al., 1990. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. The Journal of Pathology 162, 285-294.
11. Hristov, G., Kramer, M., Li, J., El-Andaloussi, N., Mora, R., Daeffler, L., et al., 2010. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. Journal of Virology 84, 5909-5922.
12. Kleinberger, T., 2000. Induction of apoptosis by adenovirus E4orf4 protein. Apoptosis: An International Journal on Programmed Cell Death 5, 211-215.
13. Kumar, G.R., Saxena, S., Saxena, L., Chaturvedi, U., Santra, L., Kumar, R., et al., 2012. In vitro expression studies of non structural 1 protein of Canine Parvo virus 2 by polyclonal antiserum raised against CPV2-NS1 protein expressed in Escherichia coli as an antigen. Indian Journal of Experimental Biology 50, 618-624.
14. Marzo, A.L., Kinnear, B.F., Lake, R.A., Frelinger, J.J., Collins, E.J., Robinson, B.W., et al., 2000. Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. Journal of Immunology 165, 6047-6055.
15. Moehler, M.H., Zeidler, M.,Wilsberg, V., Cornelis, J.J.,Woelfel, T., Rommelaere, J., Galle, P.R., Heike, M., 2005. Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and crosspresentation by dendritic cells. Human Gene Therapy 16, 996-1005.
16. Moldovan, G.L., Pfander, B., Jentsch, S., 2007. PCNA, the maestro of the replication fork. Cell 129, 665-679.
17. Morita, E., Nakashima, A., Asao, H., Sato, H., Sugamura, K., 2003. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase. Journal of Virology 77, 2915-2921.
18. Muthumani, K., Choo, A.Y., Hwang, D.S., Ugen, K.E., Weiner, D.B., 2004. HIV-1 Vpr: enhancing sensitivity of tumors to apoptosis. Current Drug Delivery 1, 335- 344.
19. Nuesch, J.P., Rommelaere, J., 2006. NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity. Journal of Virology 80, 4729-4739.
20. Nuesch, J.P., Christensen, J., Rommelaere, J., 2001. Initiation of minute virus of mice DNA replication is regulated at the level of origin unwinding by atypical protein kinase C phosphorylation of NS1. Journal of Virology 75, 5730-5739.
21. Op De Beeck, A., Sobczak-Thepot, J., Sirma, H., Bourgain, F., Brechot, C., Caillet-Fauquet, P., 2001. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1). Journal of Virology 75, 11071-11078.
22. Ploton, D., Menager, M., Jeannesson, P., Himber, G., Pigeon, F., Adnet, J.J., 1986. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. The Histochem Journal 18, 5-14.
23. Prins, R.M., Vo, D.D., Khan-Farooqi, H., Yang,M.Y., Soto, H., Economou, J.S., et al., 2006. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. Journal of Immunology 177, 8448-8455.
24. Rodriguez-Nieto, S., Zhivotovsky, B., 2006. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Current Pharmaceutical Design 12, 4411-4425.
25. Ruggeri, B., DiRado, M., Zhang, S.Y., Bauer, B., Goodrow, T., Klein-Szanto, A.J., 1993. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proceedings of the National Academy of Sciences of the United States of America 90, 1013-1017.
26. Santra, L., Rajmani, R.S., Ravi Kumar, G.V.P.P.S., Dhara, S.K., Saxena, S., Sahoo, A.P., et al., 2014. In vitro cloning of canine parvovirus NS1 gene and reporter gene GFP in eukaryotic expression vector pVIVO2-mcs and characterization of the double gene construct in mammalian cells. Indian Journal of Biotechnology 13, 41-46.
27. Saxena, L., Chaturvedi, U., Saxena, S., Kumar, G.R., Sahoo, A.P., Kumar, S., et al., 2011. Characterization and in vitro expression of non-structural 1 protein of canine parvovirus (CPV-2) in mammalian cell line. Indian Journal of Experimental Biology 49, 654-659.
28. Saxena, L., Kumar, G.R., Saxena, S., Chaturvedi, U., Sahoo, A.P., Singh, L.V., et al., 2013. Apoptosis induced by NS1 gene of Canine Parvovirus-2 is caspase dependent and p53 independent. Virus Research 173, 426-430.
29. Scott, R.J., Hall, P.A., Haldane, J.S., van Noorden, S., Price, Y., Lane, D.P., et al., 1991. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. The Journal of Pathology 165, 173-178.
30. Smyth, M.J., Godfrey, D.I., Trapani, J.A., 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology 2, 293-299.
31. Trere, D., 2000. AgNOR staining and quantification. Micron (Oxford, England: 1993) 31, 127-131.
32. Yu, C.C., Fletcher, C.D., Newman, P.L., Goodlad, J.R., Burton, J.C., Levison, D.A., 1992. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. The Journal of Pathology 166, 147-152.
33. Zhou, S., Zhang, M., Zhang, J., Shen, H., Tangsakar, E., Wang, J., 2011. Mechanisms of Apoptin-induced cell death. Medical Oncology 29, 2985-2991.